Pharmacological agents for soft tissue and bone infected with MRSA: Which agent and for how long?
To access this article, please choose from the options below
PII: S0020-1383(11)70126-7
doi:10.1016/S0020-1383(11)70126-7
© 2011 Elsevier Ltd. All rights reserved.
